Pfizer reports positive data from a Phase 2 study for the atopic dermatitis antibody
Pfizer (PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed...
Tag: PFE
China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
China has approved a new obesity drug from Pfizer (PFE), intensifying competition in a market that is expected to grow even...
Pfizer-backed Priovant wins FDA priority review for lead asset
Priovant Therapeutics, a company backed by Pfizer (PFE) and Roivant Sciences (ROIV), announced on Tuesday that the U.S. FDA...
ViiV says early-stage data on VH184 for HIV could support twice-yearly dosing
ViiV Healthcare (GSK) said that phase 1 data on third-generation integrase strand transfer inhibitor VH184 indicates that...
15 states sue Trump administration over changes to U.S. vaccine schedule
15 states, mostly led by Democrats, are suing the Trump administration, seeking judicial intervention to reverse recent...
Pfizer wins full FDA approval for Braftovi in colorectal cancer
The U.S. FDA on Tuesday granted traditional approval for a first-line combination regimen involving Braftovi, an oral cancer...
CDC vaccine panel to meet in March after delay
The Centers for Disease Control and Prevention ((CDC)) has assigned Mar. 18–19 as the dates for the next meeting of its...
Pfizer strikes $495M deal for obesity drug rights in China
"Through this strategic collaboration with Pfizer China, we look forward to fully integrating Sciwind Biosciences'...
CDC Deputy Director Ralph Abraham steps down
Ralph Abraham, the principal deputy director of the Centers for Disease Control and Prevention, has left that position,...
Moderna sued for violating patent linked to Pfizer/ BioNTech COVID-19 shot
Moderna (MRNA) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by...